GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MeVis Medical Solutions AG (XTER:M3V) » Definitions » Return-on-Tangible-Asset

MeVis Medical Solutions AG (XTER:M3V) Return-on-Tangible-Asset : 20.01% (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is MeVis Medical Solutions AG Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. MeVis Medical Solutions AG's annualized Net Income for the quarter that ended in Mar. 2024 was €5.32 Mil. MeVis Medical Solutions AG's average total tangible assets for the quarter that ended in Mar. 2024 was €26.59 Mil. Therefore, MeVis Medical Solutions AG's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was 20.01%.

The historical rank and industry rank for MeVis Medical Solutions AG's Return-on-Tangible-Asset or its related term are showing as below:

XTER:M3V' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 16.28   Med: 22.21   Max: 33.76
Current: 22.25

During the past 13 years, MeVis Medical Solutions AG's highest Return-on-Tangible-Asset was 33.76%. The lowest was 16.28%. And the median was 22.21%.

XTER:M3V's Return-on-Tangible-Asset is ranked better than
96.44% of 675 companies
in the Healthcare Providers & Services industry
Industry Median: 1.55 vs XTER:M3V: 22.25

MeVis Medical Solutions AG Return-on-Tangible-Asset Historical Data

The historical data trend for MeVis Medical Solutions AG's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeVis Medical Solutions AG Return-on-Tangible-Asset Chart

MeVis Medical Solutions AG Annual Data
Trend Dec13 Dec14 Dec15 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.76 22.07 16.43 26.52 16.61

MeVis Medical Solutions AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.80 30.81 13.16 23.58 20.01

Competitive Comparison of MeVis Medical Solutions AG's Return-on-Tangible-Asset

For the Health Information Services subindustry, MeVis Medical Solutions AG's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MeVis Medical Solutions AG's Return-on-Tangible-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where MeVis Medical Solutions AG's Return-on-Tangible-Asset falls into.



MeVis Medical Solutions AG Return-on-Tangible-Asset Calculation

MeVis Medical Solutions AG's annualized Return-on-Tangible-Asset for the fiscal year that ended in Sep. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Sep. 2023 )  (A: Sep. 2022 )(A: Sep. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Sep. 2023 )  (A: Sep. 2022 )(A: Sep. 2023 )
=4.92/( (31.201+28.054)/ 2 )
=4.92/29.6275
=16.61 %

MeVis Medical Solutions AG's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Sep. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Sep. 2023 )(Q: Mar. 2024 )
=5.322/( (28.054+25.131)/ 2 )
=5.322/26.5925
=20.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Mar. 2024) net income data.


MeVis Medical Solutions AG  (XTER:M3V) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


MeVis Medical Solutions AG Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of MeVis Medical Solutions AG's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


MeVis Medical Solutions AG (XTER:M3V) Business Description

Traded in Other Exchanges
Address
Caroline-Herschel-Strasse 1, Bremen, DEU, 28359
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.

MeVis Medical Solutions AG (XTER:M3V) Headlines

No Headlines